1. Instituto Nacional de Pediatría
2. INP
3. Artículos

Título :	Fluoxetine for adult overweight or obese people
Creador:	Melendez G
Nivel de acceso:	Open access
Palabras clave :	adulto Obesidad - epidemiología Obesidad - diagnóstico Obesidad - Factores de riesgo Obesidad - terapia Fluoxetina - uso terapéutico Fluoxetina - farmacología Fluoxetina - efectos adversos Sobrepeso Cambios en el Peso Corporal Obesidad Abdominal Adiposidad Ensayo Clínico Controlado Aleatorio Placebos Base de Datos adults Obesity - epidemiology Obesity - diagnosis Obesity - risck factor Obesity - therapy Fluoxetine - therapeutic use Fluoxetine - pharmacology Fluoxetine - adverse effects Overweight Body Weight Changes Obesity, Abdominal Adiposity Randomized Controlled Trial Placebos Database Obesidad Fluoxetina Sobrepeso Peso Corporal Obesity Fluoxetine Overweight Body Weight
Descripción :	Excess body weight is the sixth most important risk factor contributing to the overall burden of non-communicable diseases (NCDs) worldwide. Over the past 30 years, the prevalence ofweight gain has considerably increased in both developing and de veloped countries. According to the latest available estimates and projections, the World Health Organization (WHO) indicatedthat in 2014, approximately 1.9 billion adults aged 18 years andover were overweight and 600 million were obese (WHO 2014). In addition, the projection for the next 15 years is Not promising.If current secular trends continue at the same pace, by 2030 theestimated total numbers of overweight and obese people will be 2.16 billion and 1.12 billion ion, respectively (Kelly 2008), with mostresiding in low- and middle-income countries .It is well known that NCDs are the leading causes of death worldwide. Of the 57 million deaths that occurred in 2008, the majority (36 million) were attributed to cardiovascular diseases, diabetes, cancers and chronic respiratory diseases (WHO 2014) .Body mass index (BMI) is useful for identifying individuals whoare overweight and obese in Adult populations. BMI is calculated by dividing a person's weight over the square of his / her height (kg / m²). Individuals with a BMI ranging from 25 to 29.9 are classi fi ed being overweight, and with a BMI of ≥ 30 are consideredobese. Weight gain is associated with NCDs, including cardiovascular diseases, stroke, hypertension, osteoarthritis, fatty liver, several types of cancers, metabolic syndrome, respiratory disorders and type 2 diabetes mellitus (Haslam 2005; WHO 2014) .Obesity has become a major public The prevalence of cardiovascular disease in patients with cardiovascular disease is high, and the prevalence of cardiovascular disease in the general population is high. Excess body weight is the sixth most important risk factor con-tributing to the overall burden of non-communicable diseases(NCDs) worldwide. Over the past 30 years, the prevalence ofweight gain has considerably increased in both developing and de-veloped countries. According to the latest available estimates andprojections, the World Health Organization (WHO) indicatedthat in 2014, approximately 1.9 billion adults aged 18 years andover were overweight and 600 million were obese (WHO 2014 ).In addition, the projection for the next 15 years is not promising.If current secular trends continue at the same pace, by 2030 theestimated total numbers of over weight and obese people will be2.16 billion and 1.12 bill ion, respectively (Kelly 2008), with mostresiding in low- and middle-income countries.It is well known that NCDs are the leading causes of death world-wide. Of the 57 million deaths that occurred in 2008, the majority(36 million) were attributed to cardiovascular diseases, diabetes,cancers and chronic respiratory diseases (WHO 2014 ).Body mass index (BMI) is useful for identifying individuals whoare overweight and obese in adult populations. BMI is calculatedby dividing a person’s weight over the square of her/ his height (kg/m²). Individuals with a BMI ranging from 25 to 29.9 are classifiedas being overweight, and th ose with a BMI of ≥ 30 are consideredobese. Weight gain is associated with NCDs, including cardio-vascular diseases, stroke, hypertension, osteoarthritis, fatty liver,several types of cancers, metabolic syndrome, respiratory disordersand type 2 diabetes mellitus (Haslam 2005; WHO 2014).Obesity has become a major public he alth concern, and it alonerepresents an independent risk factor for cardiovascular disease;therefore, the global state of this condition necessitates ef fectivepreventive and therapeutic strategies to reduce its prevalence and
Colaborador(es) u otros Autores:	Serralde-Zúñiga AE Gonzalez Garay AG Rodríguez-Carmona Y Solis Galicia C
Fecha de publicación :	2015
Tipo de publicación:	Artículo
Identificador del Recurso :	10.1002/14651858.CD011688
Fuente:	Cochrane Database of Systematic Reviews 5(CD011688):1--14
URI :	http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2438
Idioma:	eng
Aparece en las colecciones:	Artículos

Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.